Racial Inclusivity in COVID-19 Vaccine Trials
African Americans know, perhaps the most, what it means to be the first to be heavily recruited yet neglected by biomedicine.

African Americans know, perhaps the most, what it means to be the first to be heavily recruited yet neglected by biomedicine.

Government and public health officials must aggressively work to end structural racism and revise laws that create racial inequalities.

On the front lines of the coronavirus pandemic response, there is an often forgotten workforce that is largely Black and Brown and female.

Racism in health care, expressed through implicit and explicit biases, is the ultimate form of suffocation.

Today, medicine and the health care system embody discourses of power that rival the law. Will these discourses inevitably serve to oppress BIPOC?

Full recovery from the COVID-19 pandemic will require new policy that promotes equity and streamlines access to social services.

Human subjects research has long been plagued by racial inequality. While flagrant abuses have been curtailed, disparities have, unfortunately, persisted.

Immigrant communities, along with communities of color and people experiencing existing health inequities, are expected to face disproportionate effects.
